Business Wire

Natalia Vodianova Joins PicsArt as Head of Aspiration

Del

PicsArt, the leading image editing app and creative social network, today announced the appointment of Natalia Vodianova, the supermodel and philanthropist, as Head of Aspiration. In this new role, Natalia will inspire and suggest opportunities to drive positive change through creativity. She has also joined the company’s advisory board.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170720005372/en/

Natalia Vodianova, the supermodel and philanthropist, joins PicsArt as Head of Aspiration. (Photo: B ...

Natalia Vodianova, the supermodel and philanthropist, joins PicsArt as Head of Aspiration. (Photo: Business Wire)

“We are thrilled to welcome a talent and role model like Natalia into our family,” said PicsArt CEO Hovhannes Avoyan. “Natalia has been deeply involved in bringing creative inspiration to the world through fashion and social commitment. She’ll help connect the fashion world and the brands and charities she works with to our creative community of 90 million monthly active users, for remixing and inspiration.”

“I’m excited to be part of a community where social sharing finally meets real engagement. PicsArt users collectively contribute millions of images a day, in a true celebration of love and colors that goes well beyond scrolling and liking. I see in it the power to ignite concrete change and bring visibility to very important causes,” said Natalia Vodianova. “I’m joining PicsArt because I believe people are capable of the most amazing things when they have full freedom and creativity in their hands and a purpose to apply them to. When users become aware of their collaborative power, engagement grows naturally.”

The role is a direct extension of Natalia’s focus on social activism and her vision of creativity, which naturally meets PicsArt’s mission of making awesome pictures to make the world a better place. In fact, Natalia sees creativity as a powerful, collaborative tool to activate people around social causes, in a fun, light and engaging way. Over the last five years, Natalia has established herself as a tech-entrepreneur by founding Elbi, a digital platform that puts creativity to the support of many different charity causes, fundraising for them and rewarding users for their activity. She will bring her strong purposeful storytelling and vision to PicsArt to inspire over 400 million people globally, who have already downloaded PicsArt, plus new users, to participate in creative programs for social good.

Late last year, Natalia helped normalize breastfeeding through her participation in the viral #TreeOfLife phenomenon that swept the Internet, fueled by PicsArt. She, along with tens of thousands of mothers globally, turned breastfeeding photos into works of art and shared them socially.

Starting today, Natalia can be followed via her PicsArt profile, picsart.com/natasupernova, where she’ll be challenging fans and the PicsArt community to be more creative. To begin, Natalia is offering access to inspirational stickers on her PicsArt profile that are free to use and edit, plus contests and challenges that are free to enter, available to everyone globally.

About PicsArt

PicsArt is the leading image editing app and creative social network. PicsArt makes it easy to step up your photo editing game, Remix pictures with friends, make stickers and share your creations with the world. It’s the one free app that lets you be truly creative with its 3000+ editing features, special effects, and nearly 10 million #freetoedit images. PicsArt has over 1 million #freetoedit community stickers, making it one of the largest open-source repositories of content in the world. With more than 400 million installs and 90 million monthly active users, PicsArt spans the globe and is available in 20 languages. PicsArt is free on iOS, Android and Windows devices. Download the app now or visit www.picsart.com for more information.

About Natalia Vodianova

Natalia Vodianova has walked hundreds of runway shows, starred in some of the most famous campaigns for top luxury and fashion brands, such as H&M, Prada, Calvin Klein, Louis Vuitton, Chanel, Gucci, and David Yurman. Nicknamed “Supernova” by her industry, Natalia is one of the most iconic supermodels over the last fifteen years and a loving hands-on mother of five children. She also established herself as a truly inspiring and active heroine of philanthropy: her charity organization, the Naked Heart Foundation, founded in 2004 by Vodianova, works to tackle the stigma of disability and ensure that every child has a loving family and a stimulating place to play. With the launch of her digital platform Elbi, she made philanthropy part of everybody's day life: empowering others to fundraise for charitable purposes, all while spreading the philosophy that every little act of love counts. She is also a board member of the Special Olympics International and an ambassador. She’s brought her philanthropic vision at many prestigious events, including the Clinton Global Initiative, Global Citizen, First Ladies’ Luncheon, Web Summit, Founders Forum, Millennial Summit, and One Young World.

Contact information

PicsArt
Jeff Roberto
press@picsart.com
or
Natalia Vodianova
Timon Afinsky
timon@elbi.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Shell, bio-bean and Coffee-Drinkers Collaborate to Help Power London’s Buses20.11.2017 00:01Pressemelding

Shell and bio-bean announce that together they are helping to power some of London’s buses using a biofuel made partly from waste coffee grounds. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005060/en/ Shell and bio-bean announce that together they are helping to power some of London's buses using a biofuel made partly from waste coffee grounds (Photo: Business Wire) The B20 biofuel contains a 20% bio-component which contains part coffee oil. The biofuel is being added to the London bus fuel supply chain and will help to power some of the buses; without need for modification. Biofuel provides a cleaner, more sustainable energy solution for buses across London’s network by decreasing emissions1. “Our Coffee Logs have already become the fuel of choice for households looking for a

Samsung Bioepis Receives Regulatory Approval for Europe's First Trastuzumab Biosimilar, ONTRUZANT®19.11.2017 22:21Pressemelding

Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) marketing authorization of ONTRUZANT ® , a biosimilar referencing Herceptin ® (trastuzumab), for the treatment of early breast cancer, metastatic breast cancer and metastatic gastric cancer. ONTRUZANT ® is the first trastuzumab biosimilar to receive regulatory approval in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005066/en/ Christopher Hansung Ko, President & CEO of Samsung Bioepis. (Photo: Business Wire) The EC approval of ONTRUZANT ® applies to all 28 European Union (EU) member states and the European Economic Area (EEA) member states of Norway, Iceland and Liechtenstein. ONTRUZANT ® will be commercial

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 16:31Pressemelding

Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00Pressemelding

AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20Pressemelding

AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute

Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11Pressemelding

The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom